Department of Cell Biology, Harvard Medical School, Boston, MA 02115.
Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115.
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):7057-7062. doi: 10.1073/pnas.1800440115. Epub 2018 Jun 18.
Metastasis remains the leading cause of cancer mortality, and reactive oxygen species (ROS) signaling promotes the metastatic cascade. However, the molecular pathways that control ROS signaling relevant to metastasis are little studied. Here, we identify SIRT3, a mitochondrial deacetylase, as a regulator of cell migration via its control of ROS signaling. We find that, although mitochondria are present at the leading edge of migrating cells, SIRT3 expression is down-regulated during migration, resulting in elevated ROS levels. This SIRT3-mediated control of ROS represses Src oxidation and attenuates focal adhesion kinase (FAK) activation. SIRT3 overexpression inhibits migration and metastasis in breast cancer cells. Finally, in human breast cancers, SIRT3 expression is inversely correlated with metastatic outcome and Src/FAK signaling. Our results reveal a role for SIRT3 in cell migration, with important implications for breast cancer progression.
转移仍然是癌症死亡的主要原因,而活性氧(ROS)信号促进转移级联。然而,控制与转移相关的 ROS 信号的分子途径研究甚少。在这里,我们确定 SIRT3(一种线粒体去乙酰化酶)作为细胞迁移的调节剂,通过其对 ROS 信号的控制。我们发现,尽管线粒体存在于迁移细胞的前缘,但 SIRT3 的表达在迁移过程中下调,导致 ROS 水平升高。这种 SIRT3 介导的 ROS 控制抑制 Src 氧化并减弱粘着斑激酶(FAK)的激活。SIRT3 过表达抑制乳腺癌细胞的迁移和转移。最后,在人类乳腺癌中,SIRT3 的表达与转移结果和Src/FAK 信号呈负相关。我们的结果揭示了 SIRT3 在细胞迁移中的作用,对乳腺癌的进展具有重要意义。